Skip to content

Effect of chamomile infusion on blood glucose, lipid profile and serum kidney functions

Evaluation of the effects of chamomile infusion consumption on metabolic responses and renal function biomarkers in patients with type 2 diabetes with diabetic participants who do not receive this intervention .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014120918329N2
Enrollment
40
Registered
2015-07-26
Start date
2015-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention group: This group will consume one cup of chamomile herbal tea (10 grams of chamomile flowers infuse for 10 min in 100 mL hot water without sugar) two times a day before m
Intervention group: This group will consume one cup of chamomile herbal tea (10 grams of chamomile flowers infuse for 10 min in 100 mL hot water without sugar) two times a day before meals (lunch and
Control group: No intervention will be done in this group.

Sponsors

Vice chancellor for research of Shahid Sadoughi University of medical sciences, Yazd, Iran
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with type 2 diabetic aged over the 30 years; not having a history of gastrointestinal, renal, hepatic and heart disorders or allergic reactions to chamomile plant; not being under insulin therapy. Exclusion criteria: consuming less than 30 % of the packed chamomile; changing the dose of medicines within the last 6 months or during the intervention; following a specific diet and changing their physical activity.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;2hour postprandial blood glucose. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;Total cholesterol. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;Triglyceride. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;Low density lipoprotein. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;High density lipoprotein. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.

Secondary

MeasureTime frame
Creatinine. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.;Urea. Timepoint: At the start of intervention and 4 weeks after the intervention. Method of measurement: Blood biochemical tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Yazdanpanah

Yazd Shahid Sadoughi University of Medical Sciences

yazd456@yahoo.com+98 35 3526 3237

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026